The study aims to assess the effect of smart watches and continuous glucose measuring devices on cardiovascular risk factors.
Informed Consent signed by the subject
Completed outpatient cardiac rehabilitation
Diagnosis of coronary heart disease
Access to a smartphone for the duration of the study
Diseases which limit physical activity including angina with incomplete revascularisation, arrhythmogenic cardiomyopathy, stroke with residual disease, and major orthopaedic disorders
Known or suspected non-compliance
Inability to follow the procedures of the investigation, e.g., due to language problems, psychological disorders, dementia, etc. of the subject
Diabetic patients receiving insulin therapy
University Hospital, Basel, Switzerland
Lead sponsor